1. Home
  2. SLDB vs JBSS Comparison

SLDB vs JBSS Comparison

Compare SLDB & JBSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Solid Biosciences Inc.

SLDB

Solid Biosciences Inc.

HOLD

Current Price

$9.29

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Logo John B. Sanfilippo & Son Inc.

JBSS

John B. Sanfilippo & Son Inc.

HOLD

Current Price

$73.63

Market Cap

1.0B

ML Signal

HOLD

Company Overview

Basic Information
Metric
SLDB
JBSS
Founded
2013
1959
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Specialty Foods
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.0B
IPO Year
2017
1994

Fundamental Metrics

Financial Performance
Metric
SLDB
JBSS
Price
$9.29
$73.63
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
11
1
Target Price
$16.36
$109.00
AVG Volume (30 Days)
893.5K
124.3K
Earning Date
05-12-2026
04-29-2026
Dividend Yield
N/A
3.26%
EPS Growth
34.97
4.57
EPS
N/A
5.26
Revenue
$8,094,000.00
$1,175,673,000.00
Revenue This Year
N/A
$5.58
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$14.40
Revenue Growth
N/A
6.18
52 Week Low
$3.79
$59.07
52 Week High
$11.45
$92.08

Technical Indicators

Market Signals
Indicator
SLDB
JBSS
Relative Strength Index (RSI) 56.37 29.04
Support Level $6.25 $67.75
Resistance Level $11.45 $73.75
Average True Range (ATR) 0.45 2.46
MACD 0.09 -1.11
Stochastic Oscillator 66.77 4.60

Price Performance

Historical Comparison
SLDB
JBSS

About SLDB Solid Biosciences Inc.

Solid Biosciences Inc is a life sciences company focused on advancing a portfolio of current and future gene therapy candidates, including SGT-003 for the treatment of Duchenne muscular dystrophy, SGT-212 for the treatment of Friedreich's ataxia, SGT-501 for the treatment of catecholaminergic polymorphic ventricular tachycardia, SGT-601 for the treatment of TNNT2-mediated dilated cardiomyopathy, and additional assets for the treatment of genetic cardiac and neuromuscular diseases. The majority of its current programs are designed to treat these diseases with gene transfer products. The company operates in a single segment, developing treatments through gene therapy and other means for patients with neuromuscular and cardiac diseases.

About JBSS John B. Sanfilippo & Son Inc.

John B Sanfilippo & Son Inc is one of the processors and distributors of peanuts, pecans, cashews, walnuts, almonds, and other nuts in the United States. These nuts are sold under a variety of private brands and the Fisher, Orchard Valley Harvest, and Sunshine Country brand names. It also markets and distributes, and in the majority of cases, manufactures or processes, a diverse product line of food and snack products, including peanut butter, almond butter, cashew butter, candy and confections, snacks and trail mixes, snack bites, sunflower kernels, dried fruit, corn snacks, sesame sticks and other sesame snack products under private brands and brand names.

Share on Social Networks: